Publications by the researcher in collaboration with Jesús Egido de los Ríos (23)

2021

  1. Bisphenol S is a haemodialysis-associated xenobiotic that is less toxic than bisphenol A

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1147-1155

2018

  1. Targeting inflammation in diabetic nephropathy: a tale of hope

    Expert Opinion on Investigational Drugs, Vol. 27, Núm. 11, pp. 917-930

2017

  1. Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 10, pp. 207-222

  2. Bisfenol (A) una toxina a tener en cuenta en el enfermo renal en hemodiálisis

    Revista Colombiana de Nefrología, Vol. 4, Núm. 1, pp. 57-68

2013

  1. Use of TOF-SIMS in vascular biology

    Methods in Molecular Biology, Vol. 1000, pp. 33-43

  2. Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice

    PLoS ONE, Vol. 8, Núm. 12

2011

  1. Animal models of cardiovascular diseases

    Journal of Biomedicine and Biotechnology, Vol. 2011

  2. Proteomic approach to the study of statin pleiotropy in kidney transplant patients

    Pharmacology, Vol. 87, Núm. 3-4, pp. 161-168

2010

  1. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes

    Diabetes, Vol. 59, Núm. 6, pp. 1292-1301

2008

  1. Proteomics in atherosclerosis

    Current Atherosclerosis Reports, Vol. 10, Núm. 3, pp. 209-215

  2. Cluster TOF-SIMS imaging: A new light for in situ metabolomics?

    Proteomics, Vol. 8, Núm. 18, pp. 3735-3745

2007

  1. Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging

    Analyst, Vol. 132, Núm. 1, pp. 24-26

  2. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

    European Journal of Pharmacology, Vol. 562, Núm. 1-2, pp. 119-129

2006

  1. Modulación mediante tratamiento con atorvastatina y/o amlodipino del perfil de proteínas liberadas por placas ateroscleróticas humanas

    Clínica e investigación en arteriosclerosis, Vol. 18, Núm. 5, pp. 167-175

2005

  1. Quest for novel cardiovascular biomarkers by proteomic analysis

    Journal of Proteome Research, Vol. 4, Núm. 4, pp. 1181-1191

2004

  1. Isolation of circulating human monocytes with high purity for proteomic analysis

    Proteomics

  2. Análisis proteómico de monocitos circulantes humanos. Aplicacíon a pacientes con síndrome coronario agudo

    Investigacion Cardiovascular, Vol. 7, Núm. 1, pp. 1-18

2003

  1. Proteomic analysis of human vessels: Application to atherosclerotic plaques

    Proteomics

  2. Simvastatin reduces NF-κB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

    Cardiovascular Research, Vol. 57, Núm. 1, pp. 168-177

2002

  1. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells

    Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58